That brings us to DexCom (NASDAQ: DXCM) and Regeneron Pharmaceuticals (NASDAQ: REGN), two healthcare leaders whose shares are down by 17% and 21% this year, respectively. Both have encountered company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback